Skip to main content

Table 4 RVP scores

From: An exploratory, randomised, crossover study to investigate the effect of nicotine on cognitive function in healthy adult smokers who use an electronic cigarette after a period of smoking abstinence

Test product

Reference product

LSMean (95% CI)

Difference in LSMeans (95% CI) Test—Reference

Tukey adjusted P-value

Cohen’s d effect size

Test product

Reference product

EPEN-0 mg (n = 38)

No Product (n = 37)

0.00487

(− 0.00276, 0.01249)

0.00255

(− 0.00516, 0.01025)

0.00232

(− 0.01127, 0.01591)

0.9897

0.11

EPEN-12 mg (n = 39)

No Product (n = 37)

0.01950

(0.01199, 0.02702)

0.00255

(− 0.00516, 0.01025)

0.01696

(0.00345, 0.03046)

0.0061*

0.80

EPEN-18 mg (n = 39)

No Product (n = 37)

0.01752

(0.01000, 0.02504)

0.00255

(− 0.00516, 0.01025)

0.01497

(0.00146, 0.02848)

0.0218*

0.71

Combustible Cigarette (n = 39)

No Product (n = 37)

0.02068

(0.01317, 0.02820)

0.00255

(− 0.00516, 0.01025)

0.01814

(0.00464, 0.03164)

0.0027*

0.85

EPEN-12 mg (n = 39)

EPEN-0 mg (n = 38)

0.01950

(0.01199, 0.02702)

0.00487

(− 0.00276, 0.01249)

0.01464

(0.00120, 0.02807)

0.0253*

0.69

EPEN-18 mg (n = 39)

EPEN-0 mg (n = 38)

0.01752

(0.01000, 0.02504)

0.00487

(− 0.00276, 0.01249)

0.01265

(− 0.00084, 0.02614)

0.0776

0.60

Combustible Cigarette (n = 39)

EPEN-0 mg (n = 38)

0.02068

(0.01317, 0.02820)

0.00487

(− 0.00276, 0.01249)

0.01581

(0.00235, 0.02928)

0.0125*

0.74

EPEN-18 mg (n = 39)

EPEN-12 mg (n = 39)

0.01752

(0.01000, 0.02504)

0.01950

(0.01199, 0.02702)

− 0.00199

(− 0.01532, 0.01134)

0.9939

0.09

Combustible Cigarette (n = 39)

EPEN-12 mg (n = 39)

0.02068

(0.01317, 0.02820)

0.01950

(0.01199, 0.02702)

0.00118

(− 0.01215, 0.01451)

0.9992

0.06

Combustible Cigarette (n = 39)

EPEN-18 mg (n = 39)

0.02068

(0.01317, 0.02820)

0.01752

(0.01000, 0.02504)

0.00317

(− 0.01012, 0.01646)

0.9648

0.15

  1. Results obtained using an ANOVA on post-product use results with fixed effects of product, period, sequence and a random effect of subject nested within sequence (*indicates p =  < 0.05). Participants with assessments flagged to indicate non-compliance, who also meet the performance outlier threshold (± 1.5 × IQR), have been excluded from the analysis of this data
  2. ANOVA, analysis of variance; IQR, interquartile range
  3. Baseline defined as − 85 to − 45 min pre-product use